Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Te-Wei Su

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 6, 2025
Impact of hepatocellular carcinoma-related prognostic factors on combined hepatocellular cholangiocarcinoma: A surgical cohort studyPo-Da Chen, Te-Wei Su, Chen-Yueh Lu, et al.
Biomedical Journal|May 20, 2026
Less Is More: A Single-Dose, Non-Waiting Neoadjuvant Immunotherapy Strategy for Hepatocellular CarcinomaKevin Kuan-Yu Chen, Tzu-Jung Lin, Te-Wei Su, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 6, 2025
Impact of hepatocellular carcinoma-related prognostic factors on combined hepatocellular cholangiocarcinoma: A surgical cohort studyPo-Da Chen, Te-Wei Su, Chen-Yueh Lu, et al.
Biomedical Journal|May 20, 2026
Less Is More: A Single-Dose, Non-Waiting Neoadjuvant Immunotherapy Strategy for Hepatocellular CarcinomaKevin Kuan-Yu Chen, Tzu-Jung Lin, Te-Wei Su, et al.
Pageof 1